Incidence, Clinical Features, and Outcomes of Late-Onset Neutropenia From Rituximab for Autoimmune Disease.
Reza ZonoziZachary Scott WallaceKaren LaliberteNoah R HuizengaJillian M RosenthalEugene P RheeFrank B CortazarJohn L NilesPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2020)
LON is common and often incidental. Most cases are reversible and respond well to filgrastim. However, LON can be associated with serious infections and thus warrants vigilant monitoring.